세계의 생명과학 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Life Science Instrumentation Market is presumed to reach the market size of nearly USD 123.25 Billion by 2032 from USD 69.1 Billion in 2023 with a CAGR of 6.64% under the study period 2024-2032.

The life science instrumentation market encompasses various instruments and devices in scientific research, laboratory diagnostics, and biotechnology applications. These instruments are essential for studying biological processes, analyzing biomolecules, and conducting genomics, proteomics, cell biology, and drug discovery experiments. It includes advanced technologies like mass spectrometry, flow cytometry, next-generation sequencing (NGS), microscopy, chromatography systems, and more. These instruments enable researchers, clinicians, and pharmaceutical companies to explore, analyze, and understand biological systems at molecular and cellular levels, contributing to advancements in healthcare, agriculture, and environmental sciences.

MARKET DYNAMICS

The rising demand for personalized medicine and precision healthcare solutions propels the global life science instrumentation market. Life science instruments play a vital role in biomarker discovery, genetic testing, and molecular diagnostics, facilitating the development of targeted therapies & personalized treatment plans for patients. Advances in genomics and proteomics technologies, enabled by sophisticated instrumentation, are accelerating the shift towards precision medicine approaches across the healthcare industry. Moreover, ongoing research and development activities in the pharmaceutical & biotechnology sectors drive the demand for advanced life science instrumentation. These instruments are indispensable for drug discovery, development, and quality control processes, supporting efforts to innovate new therapies, vaccines, and biologics. Technologies such as NGS and high-throughput screening systems are instrumental in accelerating drug discovery pipelines and improving preclinical and clinical research efficiency.

Furthermore, the growing prevalence of chronic diseases & infectious diseases and environmental challenges worldwide fuel investments in the life science instrumentation market. Diagnostic laboratories and research institutions rely on these instruments for disease surveillance, environmental monitoring, and epidemiological studies. The COVID-19 pandemic has underscored the significance of rapid diagnostic tools and molecular testing platforms, driving the adoption of PCR systems, antigen assays, and other life science instruments for pandemic preparedness and response efforts. However, the high cost associated with acquiring and maintaining sophisticated instrumentation may pose financial challenges for small laboratories and research facilities, particularly in emerging economies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Life Science Instrumentation. The growth and trends of Life Science Instrumentation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Life Science Instrumentation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technique

• Spectroscopy
• Chromatography
• Polymerase Chain Reaction
• Next-generation Sequencing
• Clinical Chemistry Analyzers
• Flow Cytometry
• Immunoassays
• Others

By Application

• Research Applications
• Clinical Applications
• Others

By End-user

• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Diagnostic Laboratories
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Life Science Instrumentation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Life Science Instrumentation market include Danaher, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., BD, Bruker, Hitachi High-Tech Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. LIFE SCIENCE INSTRUMENTATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technique
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET ANALYSIS BY TECHNIQUE

• 5.1. Overview By Technique
• 5.2. Historical and Forecast Data Analysis By Technique
• 5.3. Spectroscopy Historic and Forecast Sales By Regions
• 5.4. Chromatography Historic and Forecast Sales By Regions
• 5.5. Polymerase Chain Reaction Historic and Forecast Sales By Regions
• 5.6. Next-generation Sequencing Historic and Forecast Sales By Regions
• 5.7. Clinical Chemistry Analyzers Historic and Forecast Sales By Regions
• 5.8. Flow Cytometry Historic and Forecast Sales By Regions
• 5.9. Immunoassays Historic and Forecast Sales By Regions
• 5.10. Others Historic and Forecast Sales By Regions

6. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Research Applications Historic and Forecast Sales By Regions
• 6.4. Clinical Applications Historic and Forecast Sales By Regions
• 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Research Institutes Historic and Forecast Sales By Regions
• 7.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 7.5. Diagnostic Laboratories Historic and Forecast Sales By Regions
• 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL LIFE SCIENCE INSTRUMENTATION MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE LIFE SCIENCE INSTRUMENTATION COMPANIES

• 9.1. Life Science Instrumentation Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF LIFE SCIENCE INSTRUMENTATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Danaher
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Thermo Fisher Scientific Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Merck KGaA
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Bio-Rad Laboratories Inc.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Agilent Technologies Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Illumina Inc.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. PerkinElmer Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. BD
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Bruker
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Hitachi High-Tech Corporation
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies